Hubei Juneyao Health Drinks Co., Ltd
SSE:605388.SS
10.95 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,458.166 | 1,634.102 | 986.104 | 913.599 | 851.899 | 1,245.91 | 1,286.787 | 1,146 | 1,101.416 |
| Cost of Revenue
| 1,016.267 | 1,234.856 | 634.642 | 542.491 | 455.094 | 589.6 | 625.921 | 592.928 | 578.49 |
| Gross Profit
| 441.899 | 399.246 | 351.462 | 371.108 | 396.805 | 656.31 | 660.866 | 553.073 | 522.927 |
| Gross Profit Ratio
| 0.303 | 0.244 | 0.356 | 0.406 | 0.466 | 0.527 | 0.514 | 0.483 | 0.475 |
| Reseach & Development Expenses
| 34.642 | 25.178 | 17.969 | 12.643 | 2.006 | 2.215 | 1.507 | 1.166 | 0.823 |
| General & Administrative Expenses
| 113.799 | 105.377 | 20.472 | 15.673 | 13.68 | 13.895 | 25.51 | 11.098 | 16.483 |
| Selling & Marketing Expenses
| 144.617 | 187.771 | 186.994 | 168.785 | 125.843 | 266.089 | 291.767 | 234.479 | 266.449 |
| SG&A
| 258.416 | 293.148 | 207.467 | 184.458 | 139.523 | 279.984 | 317.277 | 245.578 | 282.932 |
| Other Expenses
| 178.354 | 0 | 53.47 | 30.851 | -4.574 | 6.446 | -0.53 | -0.175 | -1.994 |
| Operating Expenses
| 471.412 | 318.536 | 278.906 | 227.952 | 136.955 | 288.645 | 323.938 | 254.055 | 292.524 |
| Operating Income
| -29.513 | 84.653 | 93.069 | 193.237 | 289.042 | 392.363 | 349.549 | 305.216 | 234.41 |
| Operating Income Ratio
| -0.02 | 0.052 | 0.094 | 0.212 | 0.339 | 0.315 | 0.272 | 0.266 | 0.213 |
| Total Other Income Expenses Net
| -2.063 | -0.917 | -2.297 | 3.068 | 70.04 | 2.213 | 27.889 | -0.175 | 3.85 |
| Income Before Tax
| -31.576 | 83.736 | 90.772 | 196.305 | 285.209 | 394.576 | 349.019 | 305.041 | 232.416 |
| Income Before Tax Ratio
| -0.022 | 0.051 | 0.092 | 0.215 | 0.335 | 0.317 | 0.271 | 0.266 | 0.211 |
| Income Tax Expense
| 1.861 | 19.03 | 17.464 | 50.763 | 71.627 | 99.774 | 95.608 | 81.029 | 57.907 |
| Net Income
| -29.116 | 57.576 | 76.736 | 146.988 | 213.835 | 295.333 | 253.85 | 225.566 | 174.509 |
| Net Income Ratio
| -0.02 | 0.035 | 0.078 | 0.161 | 0.251 | 0.237 | 0.197 | 0.197 | 0.158 |
| EPS
| -0.05 | 0.093 | 0.18 | 0.34 | 0.5 | 0.69 | 0.71 | 1.1 | 3.49 |
| EPS Diluted
| -0.05 | 0.1 | 0.18 | 0.34 | 0.5 | 0.69 | 0.71 | 1.1 | 3.49 |
| EBITDA
| 45.754 | 134.502 | 122.41 | 224.28 | 278.288 | 412.113 | 355.177 | 321.196 | 235.739 |
| EBITDA Ratio
| 0.031 | 0.082 | 0.124 | 0.245 | 0.327 | 0.331 | 0.276 | 0.28 | 0.214 |